Tag: Monoclonal antibody

spot_imgspot_img

‘‘A living WHO guideline on drugs for COVID-19’’: The Eighth version (Seventh update) Released

The eighth version (seventh update) of a living guideline is released. It replaces earlier versions. The latest update includes a strong recommendation for the...

Sotrovimab Approval in the UK: A Monoclonal Antibody Effective Against Omicron, may work for Future Variants as well

Sotrovimab, a Monoclonal antibody already approved for mild to moderate COVID-19 in several countries gets approval by MHRA in the UK. This antibody was intelligently designed...

COVID-19: ‘Neutralising Antibody’ Trials Begins in the UK

University College London Hospitals (UCLH) has announced neutralising antibody trial against COVID-19. The announcement on 25 December 2020 says ‘’UCLH doses first patient in...

New Strains of SARS-CoV-2 (the virus responsible for COVID-19): Could ‘Neutralising Antibodies’ Approach be Answer to Rapid Mutation?

Several new strains of the virus have emerged since the pandemic began. New variants were reported as early as February 2020. The current variant...

Monoclonal Antibodies and Protein Based Drugs Could be Used to Treat COVID-19 Patients

Existing biologics such as Canakinumab (monoclonal antibody), Anakinra (monoclonal antibody) and Rilonacept (fusion protein) can be exploited as therapeutics that restrain inflammation in COVID-19...